Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China
21. Dezember 2020 02:00 ET
|
Allecra Therapeutics GmbH; Shanghai Haini Pharmaceutical Co., Ltd.
Allecra, subject to the satisfaction of terms and conditions as set forth in the Exclusive Licensing Agreement, is to receive an upfront cash payment and is eligible to receive additional development...